A study of C-reactive protein in acute ischemic stroke

 

R Panneer Selvam¹, V Premnath^2*

 

¹Assistant Professor, ²Sr. Resident, Department of General Medicine, Vinayaka Missions Medical College and Hospitals- Karaikal, Puducherry, INDIA.

Email: aravindhkrishnan94@gmail.com

 

REFEREANCE

1. Rebbeka. A, Gryssiewitz, DO, Kurian Thomas, MD DilipK.Pandey, MD, PhD, Epidemiology of Ischemic and hemorrhagic stroke: Incidence, prevalence, mortality and risk factors. neurology clinics(2008)871-895
2. Larry B et al Primary prevention of ischemic stroke. Circulation 2006; 113:e873-e923.
3. Claeslandenvall, katararinajood, Christian blomstrand, staffan, Cristiana jern and per ladenvall. Serum C-reactive protein concentration and genotype in relation to ischemic stroke subtype. Stroke 2006;37:2018-2023
4. Kerstin winbeck, MD; holgerpoppert, MD; thorleifetgen, MD; Bastian conadr, MD; Dirk sander, MD. Prognostic revelation of serial C-reactive protein measurements after first ischemic stroke. Stroke 2002;33:2459-2464
5. J.N. Panicker, M. Thomas, k.pavithran, D.nair, P.S. Sarma. Morbidity predictors in ischemic stroke. neurology India. January-march 2003 vol 51 isuue1.
6. J.donald Easton et al Definition and evaluation of transient ischemic stroke. stroke. 2009; 40:2276-2293.